{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:27:51Z","timestamp":1778660871712,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1186\/1479-5876-5-70","type":"journal-article","created":{"date-parts":[[2007,12,27]],"date-time":"2007-12-27T19:13:13Z","timestamp":1198782793000},"source":"Crossref","is-referenced-by-count":85,"title":["Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and -M1, a retrospective cross sectional study"],"prefix":"10.1186","volume":"5","author":[{"given":"Jan","family":"Oldenburg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigrid M","family":"Kraggerud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Bryd\u00f8y","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milada","family":"Cvancarova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ragnhild A","family":"Lothe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie D","family":"Fossa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,12,27]]},"reference":[{"key":"230_CR1","first-page":"3275","volume":"41","author":"LH Einhorn","year":"1981","unstructured":"Einhorn LH: Testicular Cancer As A Model for A Curable Neoplasm - the Richard-And-Hinda-Rosenthal-Foundation Award Lecture1. Cancer Res. 1981, 41: 3275-3280.","journal-title":"Cancer Res"},{"key":"230_CR2","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.1073\/pnas.072067999","volume":"99","author":"LH Einhorn","year":"2002","unstructured":"Einhorn LH: Curing metastatic testicular cancer. Proc Natl Acad Sci U S A. 2002, 99: 4592-4595. 10.1073\/pnas.072067999.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"230_CR3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1080\/02841860310023174","volume":"43","author":"SD Fossa","year":"2004","unstructured":"Fossa SD: Long-term sequelae after cancer therapy - Survivorship after treatment for testicular cancer. Acta Oncologica. 2004, 43: 134-141. 10.1080\/02841860310023174.","journal-title":"Acta Oncologica"},{"key":"230_CR4","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1200\/JCO.1996.14.11.2923","volume":"14","author":"C Bokemeyer","year":"1996","unstructured":"Bokemeyer C, Berger CC, Kuczyk MA, Schmoll HJ: Evaluation of long-term toxicity after chemotherapy for testicular cancer. J Clin Oncol. 1996, 14: 2923-2932.","journal-title":"J Clin Oncol"},{"key":"230_CR5","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1056\/NEJM198706043162302","volume":"316","author":"SD Williams","year":"1987","unstructured":"Williams SD, Birch R, Einhorn LH, Irwin L, Greco FA, Loehrer PJ: Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. The New England Journal Of Medicine. 1987, 316: 1435-1440.","journal-title":"The New England Journal Of Medicine"},{"key":"230_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1081\/CNV-120018236","volume":"21","author":"V Constance","year":"2003","unstructured":"Constance V: Chemotherapy-Induced Peripheral Neuropathy. Cancer Investigation. 2003, 21: 439-451. 10.1081\/CNV-120018236.","journal-title":"Cancer Investigation"},{"key":"230_CR7","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1054\/bjoc.2001.2006","volume":"85","author":"M von Schlippe","year":"2001","unstructured":"von Schlippe M, Fowler CJ, Harland SJ: Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: time course and prognosis. British Journal of Cancer. 2001, 85: 823-826. 10.1054\/bjoc.2001.2006.","journal-title":"British Journal of Cancer"},{"key":"230_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/annonc\/mdf058","volume":"13","author":"D Strumberg","year":"2002","unstructured":"Strumberg D, Brugge S, Korn MW, Koeppen S, Ranft J, Scheiber G, Reiners C, Mockel C, Seeber S, Scheulen ME: Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer. Ann Oncol. 2002, 13: 229-236. 10.1093\/annonc\/mdf058.","journal-title":"Ann Oncol"},{"key":"230_CR9","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/bjc.1998.226","volume":"77","author":"C Bokemeyer","year":"1998","unstructured":"Bokemeyer C, Berger CC, Hartmann JT, Kollmannsberger C, Schmoll HJ, Kuczyk MA, Kanz L: Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer. Br J Cancer. 1998, 77: 1355-1362.","journal-title":"Br J Cancer"},{"key":"230_CR10","first-page":"1193","volume":"13","author":"C Stava","year":"2005","unstructured":"Stava C, Beck M, Schultz PN, Vassilopoulou-Sellin R: Hearing loss among cancer survivors1. Oncology Reports. 2005, 13: 1193-1199.","journal-title":"Oncology Reports"},{"key":"230_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0378-5955(99)00190-2","volume":"140","author":"A Ekborn","year":"2000","unstructured":"Ekborn A, Laurell G, Andersson A, Wallin I, Eksborg S, Ehrsson H: Cisplatin-induced hearing loss: influence of the mode of drug administration in the guinea pig1. Hearing Research. 2000, 140: 38-44. 10.1016\/S0378-5955(99)00190-2.","journal-title":"Hearing Research"},{"key":"230_CR12","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/carcin\/18.4.641","volume":"18","author":"LW Harries","year":"1997","unstructured":"Harries LW, Stubbins MJ, Forman D, Howard GCW, Wolf CR: Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis. 1997, 18: 641-644. 10.1093\/carcin\/18.4.641.","journal-title":"Carcinogenesis"},{"key":"230_CR13","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/jnci\/94.12.936","volume":"94","author":"J Stoehlmacher","year":"2002","unstructured":"Stoehlmacher J, Park DJ, Zhang W, Groshen S, Tsao-Wei DD, Yu MC, Lenz HJ: Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer. Journal of the National Cancer Institute. 2002, 94: 936-942.","journal-title":"Journal of the National Cancer Institute"},{"key":"230_CR14","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1158\/1078-0432.CCR-04-1250","volume":"11","author":"S Hohaus","year":"2005","unstructured":"Hohaus S, Di Ruscio A, Di Febo A, Massini G, D'Alo' F, Guidi F, Mansueto G, Voso MT, Leone G: Glutathione S-transferase P1 genotype and prognosis in Hodgkin's lymphoma. Clin Cancer Res. 2005, 11: 2175-2179. 10.1158\/1078-0432.CCR-04-1250.","journal-title":"Clin Cancer Res"},{"key":"230_CR15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0009-2797(97)00154-3","volume":"111-112","author":"I Listowsky","year":"1998","unstructured":"Listowsky I, Rowe JD, Patskovsky YV, Tchaikovskaya T, Shintani N, Novikova E, Nieves E: Human testicular glutathione S-transferases: insights into tissue-specific expression of the diverse subunit classes. Chem Biol Interact. 1998, 111-112: 103-112. 10.1016\/S0009-2797(97)00154-3.","journal-title":"Chem Biol Interact"},{"key":"230_CR16","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1097\/01.ju.0000122901.70300.20","volume":"171","author":"T Kobayashi","year":"2004","unstructured":"Kobayashi T, Fujii T, Jo Y, Kinugawa K, Fujisawa M: Possible mechanism responsible for the acquisition of resistance to cis-diamminedichloroplatinum (II) by cultured human testicular seminoma cells. Journal of Urology. 2004, 171: 1929-1933. 10.1097\/01.ju.0000122901.70300.20.","journal-title":"Journal of Urology"},{"key":"230_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0378-5955(99)00136-7","volume":"137","author":"DS Whitlon","year":"1999","unstructured":"Whitlon DS, Wright LS, Nelson SA, Szakaly R, Siegel FL: Maturation of cochlear glutathione-S-transferases correlates with the end of the sensitive period for ototoxicity1. Hearing Research. 1999, 137: 43-50. 10.1016\/S0378-5955(99)00136-7.","journal-title":"Hearing Research"},{"key":"230_CR18","first-page":"349","volume":"16","author":"MA Philbert","year":"1995","unstructured":"Philbert MA, Beiswanger CM, Manson MM, Green JA, Novak RF, Primiano T, Reuhl KR, Lowndes HE: Glutathione S-Transferases and Gamma-Glutamyl-Transpeptidase in the Rat Nervous-System - A Basis for Differential Susceptibility to Neurotoxicants. Neurotoxicology. 1995, 16: 349-362.","journal-title":"Neurotoxicology"},{"key":"230_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.nbd.2004.09.013","volume":"18","author":"ES McDonald","year":"2005","unstructured":"McDonald ES, Randon KR, Knight A, Windebank AJ: Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: a potential mechanism for neurotoxicity195. Neurobiol Dis. 2005, 18: 305-313. 10.1016\/j.nbd.2004.09.013.","journal-title":"Neurobiol Dis"},{"key":"230_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev.pharmtox.45.120403.095857","volume":"45","author":"JD Hayes","year":"2005","unstructured":"Hayes JD, Flanagan JU, Jowsey IR: Glutathione transferases1. Annual Review of Pharmacology and Toxicology. 2005, 45: 51-88. 10.1146\/annurev.pharmtox.45.120403.095857.","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"230_CR21","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/sj.onc.1209373","volume":"25","author":"CC McIlwain","year":"2006","unstructured":"McIlwain CC, Townsend DM, Tew KD: Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene. 2006, 25: 1639-1648. 10.1038\/sj.onc.1209373.","journal-title":"Oncogene"},{"key":"230_CR22","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1200\/JCO.2006.08.9599","volume":"25","author":"J Oldenburg","year":"2007","unstructured":"Oldenburg J, Kraggerud SM, Cvancarova M, Lothe RA, Fossa SD: Cisplatin-Induced Long-Term Hearing Impairment Is Associated With Specific Glutathione S-Transferase Genotypes in Testicular Cancer Survivors. J Clin Oncol. 2007, 25: 708-714. 10.1200\/JCO.2006.08.9599.","journal-title":"J Clin Oncol"},{"key":"230_CR23","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1200\/JCO.2003.08.163","volume":"21","author":"SD Fossa","year":"2003","unstructured":"Fossa SD, Dahl AA, Loge JH: Fatigue, anxiety, and depression in long-term survivors of testicular cancer. J Clin Oncol. 2003, 21: 1249-1254. 10.1200\/JCO.2003.08.163.","journal-title":"J Clin Oncol"},{"key":"230_CR24","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1093\/jnci\/dji339","volume":"97","author":"M Brydoy","year":"2005","unstructured":"Brydoy M, Fossa SD, Klepp O, Bremnes RM, Wist EA, Wentzel-Larsen T, Dahl O: Paternity following treatment for testicular cancer. J Natl Cancer Inst. 2005, 97: 1580-1588.","journal-title":"J Natl Cancer Inst"},{"key":"230_CR25","doi-asserted-by":"crossref","first-page":"832","DOI":"10.2144\/98245dt04","volume":"24","author":"T Kristensen","year":"1998","unstructured":"Kristensen T, Kristensen VN, Borresen-Dale AL: High-throughput screening for known mutations by automated analysis of single sequencing reactions. Biotechniques. 1998, 24: 832-835.","journal-title":"Biotechniques"},{"key":"230_CR26","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/BF01845761","volume":"4","author":"SD Fossa","year":"1996","unstructured":"Fossa SD, Moynihan C, Serbouti S: Patients' and doctors' perception of long-term morbidity in patients with testicular cancer clinical stage I. A descriptive pilot study7. Support Care Cancer. 1996, 4: 118-128. 10.1007\/BF01845761.","journal-title":"Support Care Cancer"},{"key":"230_CR27","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s11136-005-5370-6","volume":"15","author":"J Oldenburg","year":"2006","unstructured":"Oldenburg J, Fossa SD, Dahl AA: Scale for chemotherapy-induced long-term neurotoxicity (SCIN): Psychometrics, validation, and findings in a large sample of testicular cancer survivors. Quality of Life Research. 2006, 15: 791-800. 10.1007\/s11136-005-5370-6.","journal-title":"Quality of Life Research"},{"key":"230_CR28","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1152\/jn.2002.88.2.699","volume":"88","author":"JA Kaltenbach","year":"2002","unstructured":"Kaltenbach JA, Rachel JD, Mathog TA, Zhang JS, Falzarano PR, Lewandowski M: Cisplatin-induced hyperactivity in the dorsal cochlear nucleus and its relation to outer hair cell loss: Relevance to tinnitus. Journal of Neurophysiology. 2002, 88: 699-714.","journal-title":"Journal of Neurophysiology"},{"key":"230_CR29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2165\/00002512-200421050-00002","volume":"21","author":"N Ahmad","year":"2004","unstructured":"Ahmad N, Seidman M: Tinnitus in the older adult: epidemiology, pathophysiology and treatment options3. Drugs Aging. 2004, 21: 297-305. 10.2165\/00002512-200421050-00002.","journal-title":"Drugs Aging"},{"key":"230_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1053\/j.seminoncol.2005.12.010","volume":"33","author":"FH Hausheer","year":"2006","unstructured":"Hausheer FH, Schilsky RL, Bain S, Berghorn EJ, Lieberman F: Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Seminars in Oncology. 2006, 33: 15-49. 10.1053\/j.seminoncol.2005.12.010.","journal-title":"Seminars in Oncology"},{"key":"230_CR31","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/ijc.22345","volume":"120","author":"L Richiardi","year":"2007","unstructured":"Richiardi L, Scelo G, Boffetta P, Hemminki K, Pukkala E, Olsen JH, Weiderpass E, Tracey E, Brewster DH, McBride ML, Kliewer EV, Tonita JM, Pompe-Kirn V, Kee-Seng C, Jonasson JG, Martos C, Brennan P: Second malignancies among survivors of germ-cell testicular cancer: A pooled analysis between 13 cancer registries. International Journal of Cancer. 2007, 120: 623-631. 10.1002\/ijc.22345.","journal-title":"International Journal of Cancer"},{"key":"230_CR32","doi-asserted-by":"publisher","first-page":"11592","DOI":"10.1073\/pnas.191211198","volume":"98","author":"JM Allan","year":"2001","unstructured":"Allan JM, Wild CP, Rollinson S, Willett EV, Moorman AV, Dovey GJ, Roddam PL, Roman E, Cartwright RA, Morgan GJ: Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia. Proceedings of the National Academy of Sciences of the United States of America. 2001, 98: 11592-11597. 10.1073\/pnas.191211198.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"230_CR33","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/00008571-200210000-00006","volume":"12","author":"TM Ishimoto","year":"2002","unstructured":"Ishimoto TM, Ali-Osman F: Allelic variants of the human glutathione S-transferase P1 gene confer differential cytoprotection against anticancer agents in Escherichia coli. Pharmacogenetics. 2002, 12: 543-553. 10.1097\/00008571-200210000-00006.","journal-title":"Pharmacogenetics"},{"key":"230_CR34","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1006\/abbi.1994.1233","volume":"311","author":"SS Singhal","year":"1994","unstructured":"Singhal SS, Zimniak P, Awasthi S, Piper JT, He NG, Teng JI, Petersen DR, Awasthi YC: Several closely related glutathione S-transferase isozymes catalyzing conjugation of 4-hydroxynonenal are differentially expressed in human tissues. Arch Biochem Biophys. 1994, 311: 242-250. 10.1006\/abbi.1994.1233.","journal-title":"Arch Biochem Biophys"},{"key":"230_CR35","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1158\/1078-0432.CCR-05-2076","volume":"12","author":"T Lecomte","year":"2006","unstructured":"Lecomte T, Landi B, Beaune P, Laurent-Puig P, Loriot MA: Glutathione S-transferase P1 polymorphism (Ile(105)Val) predicts cumulative neuropathy in patients receiving oxaliplatin-based chemotherapy. Clin Cancer Res. 2006, 12: 3050-3056. 10.1158\/1078-0432.CCR-05-2076.","journal-title":"Clin Cancer Res"},{"key":"230_CR36","first-page":"425","volume":"16","author":"CM Beiswanger","year":"1995","unstructured":"Beiswanger CM, Diegmann MH, Novak RF, Philbert MA, Graessle TL, Reuhl KR, Lowndes HE: Developmental-Changes in the Cellular-Distribution of Glutathione and Glutathione S-Transferases in the Murine Nervous-System. Neurotoxicology. 1995, 16: 425-440.","journal-title":"Neurotoxicology"},{"key":"230_CR37","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1200\/JCO.2002.07.061","volume":"20","author":"S Cascinu","year":"2002","unstructured":"Cascinu S, Catalano V, Cordella L, Labianca R, Giordani P, Baldelli AM, Beretta GD, Ubiali E, Catalano G: Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: A randomized, double-blind, placebo-controlled trial. J Clin Oncol. 2002, 20: 3478-3483. 10.1200\/JCO.2002.07.061.","journal-title":"J Clin Oncol"},{"key":"230_CR38","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1093\/emboj\/18.5.1321","volume":"18","author":"V Adler","year":"1999","unstructured":"Adler V, Yin ZM, Fuchs SY, Benezra M, Rosario L, Tew KD, Pincus MR, Sardana M, Henderson CJ, Wolf CR, Davis RJ, Ronai Z: Regulation of JNK signaling by GSTp. Embo Journal. 1999, 18: 1321-1334. 10.1093\/emboj\/18.5.1321.","journal-title":"Embo Journal"},{"key":"230_CR39","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/S0076-6879(05)01007-4","volume":"401","author":"CJ Henderson","year":"2005","unstructured":"Henderson CJ, Wolf CR: Disruption of the glutathione transferase pi class genes. Methods Enzymol. 2005, 401: 116-135. 10.1016\/S0076-6879(05)01007-4.","journal-title":"Methods Enzymol"},{"key":"230_CR40","doi-asserted-by":"publisher","first-page":"9217","DOI":"10.1158\/0008-5472.CAN-04-1581","volume":"64","author":"J Wang","year":"2004","unstructured":"Wang J, Ladrech S, Pujol R, Brabet P, Van De Water TR, Puel JL: Caspase Inhibitors, but not c-Jun NH2-Terminal Kinase Inhibitor Treatment, Prevent Cisplatin-Induced Hearing Loss. Cancer Res. 2004, 64: 9217-9224. 10.1158\/0008-5472.CAN-04-1581.","journal-title":"Cancer Res"},{"key":"230_CR41","doi-asserted-by":"publisher","first-page":"12749","DOI":"10.1074\/jbc.M005561200","volume":"276","author":"SG Cho","year":"2001","unstructured":"Cho SG, Lee YH, Park HS, Ryoo K, Kang KW, Park J, Eom SJ, Kim MJ, Chang TS, Choi SY, Shim J, Kim Y, Dong MS, Lee MJ, Kim SG, Ichijo H, Choi EJ: Glutathione S-transferase Mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1. Journal of Biological Chemistry. 2001, 276: 12749-12755. 10.1074\/jbc.M005561200.","journal-title":"Journal of Biological Chemistry"},{"key":"230_CR42","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1200\/JCO.2003.05.139","volume":"21","author":"A Pace","year":"2003","unstructured":"Pace A, Savarese A, Picardo M, Maresca V, Pacetti U, Del Monte G, Biroccio A, Leonetti C, Jandolo B, Cognetti F, Bove L: Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. J Clin Oncol. 2003, 21: 927-931. 10.1200\/JCO.2003.05.139.","journal-title":"J Clin Oncol"},{"key":"230_CR43","doi-asserted-by":"publisher","first-page":"4028","DOI":"10.1200\/JCO.2007.13.5251","volume":"25","author":"HS Hochster","year":"2007","unstructured":"Hochster HS, Grothey A, Childs BH: Use of calcium and magnesium salts to reduce oxaliplatin-related neurotoxicity. J Clin Oncol. 2007, 25: 4028-4029. 10.1200\/JCO.2007.13.5251.","journal-title":"J Clin Oncol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-5-70.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1479-5876-5-70\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-5-70.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T05:20:14Z","timestamp":1548134414000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/1479-5876-5-70"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["230"],"URL":"https:\/\/doi.org\/10.1186\/1479-5876-5-70","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12]]},"article-number":"70"}}